课题基金 / 基金详情

Integrative Training Program in Cancer Biology

Integrative Training Program in Cancer Biology
癌症生物学综合培训计划
批准号:
10714789
负责人:
Azeddine Atfi
金额:
$24.93万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30

项目摘要

项目成果

Azeddine Atfi的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 该提案寻求支持启动一项新的“癌症生物学综合培训”(ITCB)计划,该计划 将由隶属于梅西癌症中心(MCC)的一群精选的癌症科学家监督 弗吉尼亚联邦大学(VCU),一个拥有47年历史的国家癌症研究所指定的癌症中心。这个 该计划将为博士后和博士后参与者提供当代癌症生物学培训, 由于癌症生物学领域传统上代表性不足的个人,包括女性,将获得优先机会, 种族/民族少数群体、来自弱势背景的个人,以及那些家庭可能 经历根深蒂固的世代健康不平等。已知的高级培训中的国家不平等 机会和卫生保健是相互关联的,并从本质上塑造了彼此。正是在这种情况下, ITCB计划,该计划不仅将提供最当代的癌症生物学培训,而且还将是一种有意的 专注于开发科学方法,旨在解决癌症差异和 社区参与研究,最终将成功地抵消面临的重大癌症差异 不仅是MCC的直接集水区,而且是全国各地。ITCB计划旨在提供一个 每年对3名博士后学员和1名博士后学员进行为期两年的培训,共20名 五年项目期内的受训人员。ITCB方案的主要方案目标是1)匹配 受训者将与导师团队一起发展量身定制的癌症生物学-培训经验和职业生涯 发展计划;2)展示将社区参与纳入设计的最佳实践; 实施和传播研究成果;3)为以下领域的专家提供讲习班和实践培训 尖端生物技术;4)通过独特的癌症生物学课程提供互动参与 灌输社区参与和癌症差异的原则;癌症生物学期刊俱乐部;以及 ITCB项目每月会议,讨论正在进行的研究,癌症科学的最新进展,以及 实验室管理和职业发展的最佳做法;5)促进跨学科参与 通过MCC赞助的项目会议、研讨会和务虚会;6)提供在全国范围内建立网络的机会 通过参加专业的癌症研究会议;以及7)支持受训人员发展 校外,同行评审的拨款申请,并提交基于他们的研究的手稿。资讯科技及广播局 计划将由一名计划主任和两名副主任领导,他们有大量的 癌症生物学背景和卓越的领导经验。该计划将收到评价性输入 来自外部和内部咨询委员会,项目教职员工包括著名的MCC科学家 他们居住在出色的跨学科研究环境中,为以下方面提供了非凡的机会 由广泛的中心支持的资源支持的智力、协作交互。
英文摘要
PROJECT SUMMARY This proposal seeks support for launching a new “Integrative Training in Cancer Biology” (ITCB) program, which will be supervised by a select group of cancer scientists affiliated with the Massey Cancer Center (MCC) at the Virginia Commonwealth University (VCU), a 47-year National Cancer Institute-designated cancer center. The program will provide contemporary training in cancer biology to both predoctoral and postdoctoral participants, with priority opportunities given to traditionally underrepresented individuals in cancer biology, including women, racial/ethnic minorities, individuals from disadvantaged backgrounds, and those whose families have likely experienced deep-rooted generational health inequalities. Known national inequality in advanced training opportunities and health care are interrelated and intrinsically shape each other. It is within this context that the ITCB program, which will not only provide the most contemporary training in cancer biology but also an intentional focus on developing scientific approaches designed to address cancer disparities and the important role of community engagement in research, will ultimately succeed in offsetting the significant cancer disparities faced not only by MCC’s immediate catchment area but throughout the nation. The ITCB program aims to provide a two-year training experience to three new predoctoral trainees and one postdoctoral trainee each year, 20 total trainees over the five-year project period. The main programmatic objectives of the ITCB program are to 1) match trainees with a mentorship team who will develop a tailored cancer biology-training experience and career development plan; 2) demonstrate best practices for incorporating community engagement into the design, implementation, and dissemination of research; 3) provide workshops and hands-on training with experts in cutting-edge biotechnologies; 4) offer interactive engagement through a unique cancer biology curriculum infused with the principles of community engagement and cancer disparities; a cancer biology journal club; and an ITCB program monthly meeting to discuss research in progress, the latest advances in cancer science, and best practices for laboratory management and career development; 5) promote interdisciplinary engagement through MCC-sponsored program meetings, seminars, and retreats; 6) afford opportunities to network nationally through attendance at professional cancer research conferences; and 7) support trainees in developing extramural, peer-reviewed grant applications and submitting manuscripts based on their research. The ITCB program will be under the leadership of a Program Director and two Associate Directors who have substantial backgrounds in cancer biology and notable leadership experiences. The program will receive evaluative input from an external and an internal advisory committee, and the program faculty includes prominent MCC scientists who reside in an outstanding interdisciplinary research environment that offers remarkable opportunities for intellectual, collaborative interactions supported by extensive center-supported resources.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer Biology Program
  • 批准号:
    10391878
  • 项目类别:
  • 资助金额:
    $4.37万
  • 财政年份:
    2021
  • 负责人:
    Azeddine Atfi
  • 依托单位:
Targeting Transglutaminase 2 in cancer cachexia
  • 批准号:
    10442384
  • 项目类别:
  • 资助金额:
    $32.45万
  • 财政年份:
    2020
  • 负责人:
    Azeddine Atfi
  • 依托单位:
Targeting Transglutaminase 2 in cancer cachexia
  • 批准号:
    10174890
  • 项目类别:
  • 资助金额:
    $33.12万
  • 财政年份:
    2020
  • 负责人:
    Azeddine Atfi
  • 依托单位:
Targeting Transglutaminase 2 in cancer cachexia
  • 批准号:
    10032715
  • 项目类别:
  • 资助金额:
    $32.21万
  • 财政年份:
    2020
  • 负责人:
    Azeddine Atfi
  • 依托单位:
海外基金